# Calprotectin and Ischemia Modified Albumin Serum to Measure Disease Activity in Behçet's Disease

> **NCT05868538** · — · COMPLETED · sponsor: **Mansoura University** · enrollment: 60 (actual)

## Conditions studied

- Behçet's Diseasecases

## Interventions

- **DIAGNOSTIC_TEST:** Serum calprotectin and IMA concentrations

## Key facts

- **NCT ID:** NCT05868538
- **Lead sponsor:** Mansoura University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-01
- **Primary completion:** 2023-03-01
- **Final completion:** 2023-03-15
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2023-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05868538

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05868538, "Calprotectin and Ischemia Modified Albumin Serum to Measure Disease Activity in Behçet's Disease". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05868538. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*